GT Biopharma Announces Preclinical Results For Its ROR1 TriKE™ As A Treatment For Prostate Cancer

BEVERLY HILLS, Calif., March 8, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…

Personalized Medicine Is The Next Big Trend For Biotech Stocks & 1 Company Could Radically Disrupt The Industry

Personalized Medicine Should Be At The Top Of Your List In 2021 & Here’s Why

GT Biopharma Adds University of Wisconsin–Madison Carbone Cancer Center as Second Site in Ongoing Phase 1/2 Clinical Trial of GTB-3550 TriKE™, a Novel NK Cell Therapeutic Cancer Treatment

BEVERLY HILLS, Calif., March 4, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…

“Pick & Shovel” Companies Could Provide Opportunity Within the Medical Industry in 2021

2021 May Bring New Potential for Emerging Trends in Healthcare

Havn Life Sciences to Host Investor Webcast on March 3, 2021

Attendees will have the opportunity to get the latest updates and participate…